Research Grant Recipients

HomeImpact ▶ Research Grant Recipients
2025 Research Grant Recipients

The American Thoracic Society is pleased to announce the grant and award recipients for the 2025 grant cycle. The support of our members, donors, and partners make these awards possible—thank you!

 

ALA
 
Alpha 1
 
Chest
 
FSR
 
Fisher and Paykel
 
Johnson and Johnson
 
PCD
 

 

Partner Grants

The ATS Research Program partners with other nonprofit organizations and pharmaceutical companies to maximize the number of grants we can support. The ATS reviews all grants and assumes all costs associated with administrating the grants.

John Brems, MD

Henry Brems, MD
Johns Hopkins University
ALA/ATS/CHEST Respiratory Health Equity Research Award - $200,000
Addressing Inequities from Before Medically Advised Discharges after Asthma Exacerbation

Martin Kang, PhD

Martin Kang, PhD
Medical University of South Carolina
ATS/ALA Commemorative 120th Anniversary Joint Research Award - $120,000
Redosing AAV Gene Therapy in The Lungs of a Pediatric Mouse Model of Surfactant Protein-B Deficiency

Shah Hussain, PhD

Shah Hussain, PhD
University of Alabama at Birmingham
ATS/Alpha-1 Foundation Young Investigator Grant in Alpha-1 Antitrypsin Deficiency - $50,000
Characterizing RASCs in AAT-Deficient Ferrets: Implications for COPD and Distal Airway Remodeling

Dipayan Chaudhuri, MD MSc FRCPC

Dipayan Chaudhuri, MD MSc FRCPC
McMaster University
ATS/Fisher & Paykel Healthcare Research Grant in Nasal High Flow - $50,000
Hypercapnic Respiratory Failure and High Flow Nasal Cannula (HyperFlow): A pilot randomized trial

Mark Mallozzi, MD

Mark Mallozzi, MD
National Jewish Health
ATS/Foundation for Sarcoidosis Research Grant - $100,000
Association of PM2.5 Exposure with Sarcoidosis Outcomes at Baseline and Longitudinal Follow-Up

Robert Reklow, PhD

Robert Reklow, PhD
University of British Columbia
ATS/Margaret W. Leigh/PCD Foundation Early Career Investigator Award - $60,000
AID-PCD: Assessing Immunofluorescence for Diagnosis of Primary Ciliary Dyskinesia

 

ATS Diversity Grant
($40,000)

The ATS is committed to supporting diversity in the next generation of researchers and clinicians. This award recognizes an outstanding investigator working in pulmonary, critical care, and sleep medicine that is from a  population underrepresented in the U.S. research enterprise, as defined by the NIH.

Gonzalo Labarca, MD

Gonzalo Labarca, MD
Pontificia Universidad Catolica de Chile
Sleep Apnea Physiological Burdens and Pulmonary Function in the Hispanic/Latino Community

 

ATS Unrestricted Research Grants
($40,000/ea)

The ATS funds unrestricted research grants representing the three pillars of the American Thoracic Society: pulmonary, critical care, and sleep medicine. Awards span basic, clinical, and translational research in adult and pediatric medicine. Applicants consider how their research will provide novel approaches to challenging lung diseases, foster health care equality, and improve patient outcomes.

Chaofan Li, PhD

Chaofan Li, PhD
University of Virginia
Molecular Regulation of Respiratory Immune Response Driving Lung Sequelae Post COVID-19

Monica Liu, MD, PhD

Monica Liu, MD, PhD
University of Wisconsin-Madison
Validating Patient-Derived Organoid Models of Acute Lung Transplant Rejection

Luciana Padua Taveres, PhD

Luciana Padua Taveres, PhD
Brigham and Women's Hospital - Harvard Medical School
15-Lipoxygenase-Expressing Neutrophils Reprogram Macrophages to Promote Resolution Of ARDS

Richard Ramonell, MD

Richard Ramonell, MD
University of Pittsburgh
Pathogenic Potential of CD8+ Effector Memory T Cells Re-Expressing CD45RA in Severe Asthma

B. Shoshana Zha, MD, PhD

B. Shoshana Zha, MD, PhD
The Regents of the University of California, San Francisco
MAC-BeNTM: Macrophage Response in Bronchiectasis and Pulmonary NTM Disease

 

Early Career Investigator Award in Pulmonary Vascular Disease
($100,000/ea)

The Early-Career Investigator Award in Pulmonary Vascular Disease supports scientists conducting research on the basic mechanisms and/or vascular biology of pulmonary vascular disease. This award is generously sponsored by Johnson & Johnson.

Gabriel Altit, MD

Gabriel Altit, MD
McGill University Health Centre - Research Institute / Montreal Children's Hospital
NORDIC-FU: Neonatal Outcomes Related to Early Discovery of Impaired Cardiac Function at Follow-Up

John Park, MD, PhD

John Park, MD, PhD
The Regents of the University of California, Los Angeles
Emerging role of LOXL2 in Right Heart Failure due to Pulmonary Hypertension: Novel Druggable Target

Michael Smith, MD

Michael Smith, MD
The Regents of the University of California, San Francisco
Adaptive Right Ventricular Development in Congenital Heart Disease-Pulmonary Hypertension

Bingqiang Wen, PhD

Bingqiang Wen, PhD
The Regents of the University of Arizona
Identify Mouse Lung Endothelial Cell Specific DNA Regulatory Regions in the Foxf1 Enhancer

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

X Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY (ATS)
Church Street Station
P.O. Box 3421
New York, NY 10008-3421

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.